Conference Coverage

VIDEO: Low testosterone common after testicular cancer


AT ASCO 2017

– More than one-third of testicular cancer survivors have hypogonadism, according to an analysis of nearly 500 male patients conducted by the Platinum Study Group.

Lead author Mohammad Abu Zaid, MBBS, of Indiana University, Indianapolis, discusses the implications for long-term health, screening during follow-up, testing, and testosterone replacement therapy in a video interview at the annual meeting of the American Society of Clinical Oncology.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Next Article: